NRx Pharmaceuticals, Inc. announced its 2025 Annual Meeting date and record date.
The meeting will be held on March 23, 2026, at 10:00 a.m. Eastern Time in a virtual-only format.
Stockholders as of February 12, 2026, will be entitled to notice and vote at the meeting.
2025 Annual Meeting Details
Date: March 23, 2026, Time: 10:00 a.m. Eastern Time, Virtual format.
Record Date
February 12, 2026, determines stockholders eligible to vote at the meeting.
Submission Deadline for Proposals
Stockholder proposals due by January 26, 2026, following specific guidelines.
Stockholder Proposals
Proposals not meeting the deadline may not be considered at the 2025 Annual Meeting.
- Stockholders must adhere to submission deadlines to ensure their proposals are considered. Meeting virtually allows broader participation from stockholders regardless of location. The Company's focus on treating central nervous system disorders reflects its commitment to addressing critical health issues.
NRx Pharmaceuticals' announcement of the Annual Meeting and key deadlines highlights transparency and shareholder engagement. The focus on developing treatments for mental health disorders underscores the Company's dedication to improving patient outcomes.